How Can We Use Genetic Engineering to Get Rid of Malaria for Good?
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Gene Drives for Malaria Control and Elimination in Africa
GENE DRIVES FOR MALARIA CONTROL AND ELIMINATION IN AFRICA HIGH LEVEL APET REPORT • GENE DRIVES FOR MALARIA CONTROL AND ELIMINATION IN AFRICA About the AU and NEPAD The African Union (AU) The African Union (AU) is a continental union consisting of all 55 countries on the African continent. It was established on 26 May 2001 in Addis Ababa, Ethiopia, and launched on 9 July 2002 in South Africa, with the aim of replacing the Organisation of African Unity (OAU). The most important decisions of the AU are made by the Assembly of the African Union, a semi-annual meeting of the heads of state and government of its member states. The AU’s secretariat, the African Union Commission, is based in Addis Ababa. The AU was established following the 9th September 1999 Sirte Declaration of the Heads of State and Governments of the Organisation of the African Unity (OAU). The AU is based on a common vision of a united and strong Africa and on the need to build a partnership between governments and all segments of civil society, in particular, women, the youth and the private sector, in order to strengthen solidarity and cohesion amongst the peoples of Africa. As a continental organization, it focuses on the promotion of peace, security and stability. The development work of the AU is guided by the AU Agenda 2063, which is a 50-year plan to harness Africa’s comparative advantage to deliver on the vision of “The Africa We Want”. The New Partnership for Africa’s Development (NEPAD) Created by the African Union, the New Partnership for Africa’s Development (NEPAD) is a strategic framework for Pan-African socio- economic development. -
What Is Gene Drive?
The Science: What is gene drive? What is gene drive? Gene drive is a genetic phenomenon that occurs in nature and causes a selected trait to spread rapidly through a species via sexual reproduction over several generations. Gene drive works by increasing the likelihood that a modified gene will be inherited by its offspring. Normally, genes have a 50/50 chance of being inherited, but gene drive How is Target Malaria using systems could increase that chance to upwards gene drive technology? of 99 percent. This means that over the course of several generations, a selected trait could become We aim to tackle malaria at the source. Target increasingly common within a specific species. Malaria is using gene drive approaches to insert a modification in malaria mosquitoes that would Researchers have been studying how to harness affect the mosquito’s ability to reproduce. By gene drives to solve some of society’s most reducing the population of malaria mosquitoes, intractable problems for a long time. Public health we aim to reduce the transmission of the disease. and ecosystem conservation are two of the main areas where research has focused, although other Worldwide there are more than 3,500 species of uses are also possible. mosquito, with 837 of them in Africa. Of these, a single cluster of three very closely related What are gene drive applications species are responsible for most of the malaria transmission – Anopheles gambiae, Anopheles in public health? coluzzii and Anopheles arabiensis. In public health, several proposals have been The project is investigating the use of genes that made which would use gene drive to limit the produce enzymes (called nucleases) that cut spread of diseases, particularly those spread specific sequences of DNA. -
Top Tips How to Avoid Vector Borne Diseases (Eng)
Tr a a v r e i ljl s k in a g r e to a Vectors such as mosquitoes, sandflies and HOW tO AvOid ticks can transmit serious infectious diseases both in vEctOR-BORnE the WHO European Region disEAsEs – tOp tips and globally. Many of these vectors are blood sucking and transfer diseases to Take simple measures to protect yourself and your family. human beings through their bites. 1. Before you travel, be vaccinated against diseases prevalent at your destination. vaccines exist for yellow fever, Japanese encephalitis and tick- Avoid being bitten by a borne encephalitis. mosquito, sandfly or tick. 2. consult your doctor, 4–6 weeks before departure if possible, to discuss how you can protect yourself (for example, what antimalarial medicines you Be prepared. should take if malaria is endemic at your destination). 3. Wear light-coloured, long-sleeved shirts and long trousers, tucked into socks or boots, and use insect repellent on exposed skin and clothing to protect yourself from being bitten by mosquitoes, sandflies or ticks. temperature, humidity and the time of day affect the likelihood of being bitten, so know when you need extra protective clothing and insect repellent. 4. Use window screens, if available, to keep mosquitoes outside the place where you are staying. 5. sleep under an insecticide-treated bed net, requesting one if necessary, if you are staying in an area with malaria risk. 6. check your body regularly for ticks. if you find one, remove it with tweezers and apply a skin disinfectant. in tick-infested areas, examine your clothing, luggage and other belongings thoroughly before entering the place where you are staying. -
Comprehensive Guidelines for Prevention and Control of Dengue and Dengue Haemorrhagic Fever
C o m p r e h e n s Dengue fever (DF) is the fastest emerging arboviral infection spread by Aedes aegypti i v mosquitoes with major public health consequences for millions of people around the e G world, and in particular the South-East Asia and Asia-Pacific Regions of the World u i Health Organization (WHO). Of the 2.5 billion people globally at risk of DF and its d e severe forms dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS) l i n South-East Asia accounts for approximately 1.3 billion or 52%. e s f As the disease spreads to new geographical areas, the frequency of the o r outbreaks has increased along with a rapidly changing disease epidemiology. In P r response to resolution of the Forty-sixth World Health Assembly urging Member e v States to strengthen national programmes for control of DF/DHF, several documents e n were developed by regional offices of WHO, including South-East Asia. t i o In 1999 the WHO Regional Office for South-East Asia published the Regional n a Comprehensive Guidelines for Guidelines for the Prevention and Control of DF/DHF. Since then new strategies and n d developments in the control of dengue fever, DHF and DSS have come to light. The C Regional Guidelines were extensively revised, updated and expanded with the focus o n Prevention and Control of on new and additional topics of current relevance to the populations of Member t r o States of the Region. They were then rechristened the Comprehensive Guidelines for l o the Prevention and Control of Dengue and Dengue Haemmorhagic Fever. -
Guide Yellow Fever Outbreak 2016
© World Health Organization 2016 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. -
A CRISPR Endonuclease Gene Drive Reveals Two Distinct Mechanisms of Inheritance Bias
bioRxiv preprint doi: https://doi.org/10.1101/2020.12.15.421271; this version posted December 15, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. A CRISPR endonuclease gene drive reveals two distinct mechanisms of inheritance bias Sebald A. N. Verkuijl1,2,+, Estela Gonzalez1,+, Ming Li3, Joshua Ang1, Nikolay P. Kandul3, Michelle A. E. Anderson1, Omar S. Akbari3, Michael B. Bonsall2, and Luke Alphey1,* 1Arthropod Genetics, The Pirbright Institute, Ash Road, Pirbright GU24 0NF, U.K 2Mathematical Ecology Research Group, Department of Zoology, University of Oxford, 11a Mansfield Road, Oxford OX1 3SZ, U.K 3Division of Biological Sciences, Section of Cell and Developmental Biology, University of California, La Jolla, San Diego, United States, 92093 +these authors contributed equally to this work *[email protected] ABSTRACT RNA guided CRISPR gene drives have shown the capability of biasing transgene inheritance in multiple species. Among these, homing endonuclease drives are the most developed. In this study, we report the functioning of sds3, bgcn, and nup50 expressed Cas9 in an Aedes aegypti homing split drive system targeting the white gene. We report their inheritance biasing capability, propensity for maternal deposition, and zygotic/somatic expression. Additionally, by making use of the tight linkage of white to the sex-determining locus, we were able to elucidate mechanisms of inheritance bias. We find inheritance bias through homing in double heterozygous males, but find that a previous report of the same drive occurred through meiotic drive. -
Resistance to Gene Drive
Resistance to gene drive Many existing methods of malaria control are facing difficulties in maintaining effective performance, from insecticide and drug resistance to increasing costs of interventions. Controlling the malaria vector, the mosquito, remains the frontline for disease elimination. Target Malaria aims to develop new genetic technologies in a strategy known as gene drive to reduce the malaria mosquito population and thus reduce malaria transmission. This means that both the CRISPR/Cas transgene and female infertility spread through mosquito Gene drive involves a genetic mechanism population at far greater rates than would occur designed to spread through a population by normal inheritance mechanisms, ultimately while at the same time reducing the leading to reductions in the overall numbers of mosquito population and decreasing malaria vectors. malaria transmission. Gene drive is an especially appealing strategy as it could be deployed in remote locations, can Resistance potential work in parallel with the health care system while not being dependent on it, Just as antibiotic use to treat bacterial infection is potentially cost effective, can be used can lead to drug-resistant bacteria, any method in complementarity with other vector of mosquito population control - such as the control methods and has the potential for use of insecticides - can lead to mosquitoes that long term and sustainable impact. are resistant to that method. Likewise, the risk exists that some form of resistance to the gene drive could emerge. Resistance arises through a The Target Malaria gene drive approach exploits common cause of natural selection, whatever the a transgene encoding the nuclease CRISPR/ resistance is against. -
STOA Workshop the Science and Ethics of Gene Drive Technology
STOA workshop The science and ethics of gene drive technologyCase study: Eradicating malaria Participants’ booklet EPRS | European Parliamentary Research Service Scientific Foresight Unit (STOA) EN PE 634.426 – 19 March 2019 The science and ethics of gene drive technology Case study: Eradicating malaria Participants’ booklet 19 March 2019, 08:00-09:30 Paul-Henri Spaak Building, Room PHS 7-F387 European Parliament, Brussels STOA | Panel for the Future of Science and Technology Prepared by Lieve Van Woensel and Jens Van Steerteghem, Scientific Foresight Unit (STOA) Available at http://www.europarl.europa.eu/stoa/en/events/farming-without-agro-chemicals Join the conversation on Twitter by using the hashtag #GeneDriveSTOA and by tweeting at @EP_ScienceTech © European Union, 2019 The science and ethics of gene drive technology Table of contents 1. A debate on the case of using gene drive technology for eradicating malaria _____________ 2 2. Programme__________________________________________________________________ 3 3. Speakers' biographies _________________________________________________________ 4 3.1. Kay SWINBURNE, MEP, STOA Panel member and workshop chair ____________________ 4 3.2. Jens VAN STEERTEGHEM _____________________________________________________ 5 3.3. Delphine THIZY ____________________________________________________________ 6 3.4. Sybille VAN DEN HOVE ______________________________________________________ 7 4. About STOA _________________________________________________________________ 8 4.1. Mission ___________________________________________________________________ -
Anopheles Gambiae Genome Conservation As a Resource for Rational Gene Drive Target Site Selection
insects Article Anopheles gambiae Genome Conservation as a Resource for Rational Gene Drive Target Site Selection Nace Kranjc 1 , Andrea Crisanti 1, Tony Nolan 2,* and Federica Bernardini 1,* 1 Department of Life Sciences, Imperial College, London SW7 2AZ, UK; [email protected] (N.K.); [email protected] (A.C.) 2 Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK * Correspondence: [email protected] (T.N.); [email protected] (F.B.) Simple Summary: Malaria is a huge public health burden that affects predominantly sub-Saharan Africa and is transmitted by Anopheles mosquitoes. As a measure for population control, a method called gene drive has been recently developed, which relies on genetic engineering to introduce specific genetic traits into mosquito populations. Gene drives are designed to insert at specific target sites in the mosquito genome. The efficacy of gene drives greatly depends on the selection of appropriate target sites that are functionally or structurally constrained and less likely to tolerate mutations that can hinder the spread of the desired trait in the population. The aim of this study was to perform a genome-wide analysis of highly conserved genomic regions in Anopheles gambiae and introduce a measure of conservation that could indicate sites of functional or structural constraint. The results of this analysis are gathered in a publicly available dataset that can support gene drive target selection and can offer further insights in the nature of conserved genomic regions. Abstract: The increase in molecular tools for the genetic engineering of insect pests and disease vectors, such as Anopheles mosquitoes that transmit malaria, has led to an unprecedented investigation of the genomic landscape of these organisms. -
Gene Drive: Modern Miracle Or Environmental Disaster
GENE DRIVE: MODERN MIRACLE OR ENVIRONMENTAL DISASTER Kristen D. Brooks TABLE OF CONTENTS I. Introduction ......................................................................................... 201 II. Background ......................................................................................... 203 III. Analysis ............................................................................................... 206 A. Introduction to the Oxitec Mosquito and FDA Regulation ......... 206 1. The FDA, NEPA, and GloFish .............................................. 210 2. The Flawed Environmental Assessment of the AquAdvantage Salmon .......................................................... 211 3. A Closer Look at FDA’s Environmental Assessment for Oxitec Mosquitoes ................................................................. 213 B. EPA Regulation of the Oxitec Mosquito ..................................... 215 1. EPA Ecological Risk Assessment ......................................... 216 2. Application of EPA Risk Assessment to Gene Drive Organisms .................................................................... 217 C. The Case of the Diamondback Moth ........................................... 218 IV. Recommendation ................................................................................ 220 A. New Biotechnology-Specific Legislation .................................... 221 B. Reworking NEPA: Legislative Solutions .................................... 222 C. Reworking NEPA: Administrative Solutions ............................. -
Critique of African Union and NEPAD's Positions on Gene Drive
Critique of African Union and NEPAD’s positions on gene drive mosquitoes for Malaria elimination PO Box 29170, Melville 2109, South Africa www.acbio.org.za November 2018 1 Contents Abbreviations 3 About this paper 4 1. Introduction: What are gene drives? 5 2. Target Malaria 5 3. The AU report makes numerous unsubstantiated claims in support of gene drive development 6 Claim 1: ‘Gene drives present realistic options for effective disease control’ 6 Claim 2: ‘No major risks are foreseen that cannot be mitigated’ 9 Claim 3. ‘Development of the gene drive technology should follow a stepwise approach’ 10 4. Unsubstantiated hype surrounding gene drives opens up the continent to GM insects 11 5. Questionable ethical practices involving human subjects in Burkina Faso 12 Conclusions 13 References 15 AFRICAN CENTRE FOR BIODIVERSITY – Critique of African Union and NEPAD’s positions on gene drive mosquitoes for Malaria elimination 2 On 7 April 2015 the African Centre for Biosafety officially changed its name to the African Centre for Biodiversity (ACB). This name change was agreed by consultation within the ACB to reflect the expanded scope of our work over the past few years. All ACB publications prior to this date will remain under our old name of African Centre for Biosafety and should continue to be referenced as such. We remain committed to dismantling inequalities in the food and agriculture systems in Africa and our belief in people’s right to healthy and culturally appropriate food, produced through ecologically sound and sustainable methods, and their right to define their own food and agricultural systems. -
How Can We Use Genetic Engineering to Get Rid of Malaria for Good? Teacher’S Key
How can we use genetic engineering to get rid of malaria for good? TEACher’s key Check your understanding 1 Anopheles gambiae mosquitoes are a vector species for malaria. What is a vector species? Can you find out about some other vector species and the diseases they transmit? A vector is an organism that does not cause disease itself but which spreads infection by transmitting pathogens (virus, bacteria, parasites, etc.) from one host to another. Mosquitoes are vector species of many infectious diseases including malaria, dengue, yellow fever, Zika, and West Nile virus. Some other vector species are ticks (Lyme Answer disease), fleas (bubonic plague), raccoons, bats, foxes, skunks (rabies). Scientists genetically engineered Anopheles gambiae mosquitoes. What were the characteristics of engineered 2 mosquitoes that drove the lab populations to extinction? Male mosquitoes with one or both copies of the mutated gene had no physical differences but they were carriers of the mutated gene and passed it onto their offspring. Female mosquitoes with one copy of the mutated gene were healthy but they had reduced fertility. They passed the mutated gene on to the next generation. Females with two copies of the mutated gene had male body parts (a mouth that is not structured to bite, claspers, and hairy Answer antennae). Most importantly, they were infertile - they couldn’t lay eggs. So once all females carried two copies of the mutated gene, the population collapsed. 3 Scientists used a new approach that made this study so successful at wiping out mosquito populations: CRISPR/Cas9 gene drive. What is the purpose of a gene drive? How does it speed up the spread of a useful genetic mutation? In sexual reproduction, half of the genes come from the male organism and the other half come from the female organism.